What Happened?
South San Francisco, CA-based Portola Appointed Ernie Meyer as Executive Vice President and Chief Human Resources Officer
About the Company
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
About the Person
Ernest Meyer is Executive Vice President and Chief Human Resources Officer at Portola. Previously, Ernie held various senior HR leadership roles in the industry.
Info Source
News
Short Profile